T. Rowe Price Associates’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$786K Buy
80,029
+17,726
+28% +$174K ﹤0.01% 2092
2025
Q1
$453K Buy
62,303
+15,011
+32% +$109K ﹤0.01% 2284
2024
Q4
$370K Buy
47,292
+4,976
+12% +$38.9K ﹤0.01% 2406
2024
Q3
$314K Buy
42,316
+8,134
+24% +$60.4K ﹤0.01% 2454
2024
Q2
$274K Buy
34,182
+2,961
+9% +$23.7K ﹤0.01% 2457
2024
Q1
$364K Buy
31,221
+7,000
+29% +$81.6K ﹤0.01% 2342
2023
Q4
$271K Sell
24,221
-358,024
-94% -$4.01M ﹤0.01% 2421
2023
Q3
$5.9M Buy
382,245
+361,027
+1,702% +$5.58M ﹤0.01% 1145
2023
Q2
$403K Buy
+21,218
New +$403K ﹤0.01% 2227
2021
Q2
Sell
-8,513
Closed -$202K 2924
2021
Q1
$202K Sell
8,513
-6,428
-43% -$153K ﹤0.01% 2687
2020
Q4
$364K Buy
+14,941
New +$364K ﹤0.01% 2359